Page 7 of 10 – SEC Filing CUSIP NO.
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J); (k) [ ] Group, in accordance with §240.13d-1(b)(1)(ii)(K).
Item 4. Ownership***
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned*** Cormorant Global Healthcare Master Fund, LP – 1,658,151 shares
Cormorant Global Healthcare GP, LLC – 1,658,151 shares
Cormorant Asset Management, LLC – 1,988,208 shares
Bihua Chen – 1,988,208 shares (b) Percent of Class Cormorant Global Healthcare Master Fund, LP – 8.5%
Cormorant Global Healthcare GP, LLC – 8.5%
Cormorant Asset Management, LLC – 10.1%
Bihua Chen – 10.1% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP NO. |
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) | [ ] | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | |
| (b) | [ ] | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | [ ] | Insurance Company as defined in Section 3(a)(19) of the Act | |
| (d) | [ ] | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | [ ] | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
| (f) | [ ] | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |
| (g) | [ ] | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | [ ] | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | [ ] | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | [ ] | A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J); | |
| (k) | [ ] | Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
| Item 4. | Ownership*** |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| (a) | Amount Beneficially Owned*** | ||
| Cormorant Global Healthcare Master Fund, LP – 1,658,151 shares Cormorant Global Healthcare GP, LLC – 1,658,151 shares Cormorant Asset Management, LLC – 1,988,208 shares Bihua Chen – 1,988,208 shares | |||
| (b) | Percent of Class | ||
| Cormorant Global Healthcare Master Fund, LP – 8.5% Cormorant Global Healthcare GP, LLC – 8.5% Cormorant Asset Management, LLC – 10.1% Bihua Chen – 10.1% | |||
| (c) | Number of shares as to which such person has: | ||
| (i) | sole power to vote or to direct the vote | ||
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
